Objectives: In the management of parotid sialocele and fistula, various conservative and surgical methods have been described. Some studies have described the use of Botulinum toxin A (Botox A) for the management of parotid sialocele and fistula. This is a less invasive and potentially equally effective option. We therefore conducted a systematic review on the current body of literature relating to this specific use of Botox A.
| INTRODUCTION
Parotid sialocele is defined as an accumulation of saliva in the subcutaneous tissue around the gland or duct. [1] [2] [3] This occurs because of blunt or penetrating trauma to the parotid gland or duct, or as a complication of surgery. 3 The clinical presentation includes that of a painless swelling around the parotid gland or duct and may be complicated by fistula formation and infection. 3 Though parotid sialoceles and fistulas are two different clinical entities, a parotid sialocele may progress to a parotid fistula. Hence, early appropriate treatment of a sialocele is recommended. The incidence of sialocele/fistula development has been reported to be between 2 and 6.4% in patients undergoing partial superficial parotidectomy. 3 At present, definitive evidence-based treatment guidelines for sialocele and fistula management do not exist. In the management of parotid sialocele/fistula, various conservative and surgical methods have been described. Botox A is a neurotoxin which inhibits presynaptic acetylcholine release and hence saliva production from parotid glandular tissue. 3 Its uses for facial cosmesis are widely documented. [4] [5] [6] [7] [8] It has minimal side effects when injected locally. Few studies have described the use of
Botox for the management of parotid sialocele. There is therefore a need to further explore the use, benefit, method of administration and optimal therapeutic dose of Botox A in the management of parotid sialoceles. 8 We therefore conducted a thorough literature search and formulated this review on the current body of information relating to this topic.
The aim of this systematic review was to synthesize the evidence from primary research studies and formulate recommendations on the use of Botox A injections in adult patients with parotid sialocele and fistula. were also analyzed for additional relevant resources. The search was restricted to publications in the medical literature.
| MATERIALS AND METHODS

| Search strategy
A
| Study selection
Studies included in the review met the following criteria: (a) English language, (b) availability of data, (c) patients treated medically with Botox A, and (d) clinical publications, were used as inclusion criteria.
Data points extracted from each study included number of patients, patient demographics, anatomical site of parotid affected, indications for therapy, dosage, method of Botox administration, frequency of therapy, adjunct use of other conservative measures, complications, outcomes, and average follow-up duration.
| Review study definition of botulinum use for the treatment of parotid sialocele
In this study, the use of Botox A for the medical treatment of parotid sialocele or fistula, alone or in combination with surgery or other treatment adjuncts was deemed adequate for study inclusion.
Response to Botox A was defined as any clinical or radiological outcome detected after administration of the drug.
| Data extraction and methodical evaluation
The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were applied to guide the electronic search.
Eligible articles where screened by each reviewer. The selected studies were ranked using the ROBINS-1 tool for assessing risk of bias in nonrandomized studies of interventions. Each reviewer then compiled a descriptive narrative of each study ( Table 1) . 
| Study design of included studies
All studies were retrospective and consisted of mostly case reports.
Follow-up was variable and ranged from 10 days to 21 months. A breakdown of analyzed studies can be seen in Table 2 .
| Study population of included studies
All the studies had human participants. Majority of sialoceles and fistulas presented as a complication of surgery (77%) with the remaining cases occurring as a result of trauma. Surgery performed included parotidectomy for tumor excision and Mohs micrographic surgery. Surgery was performed for diagnosis of squamous cell carcinoma in most cases.
| Age of patients
In our review of studies, which indicated the gender of patients, males were more commonly affected than females. The typical age at presentation was between 32 and 88 years of age (mean age of presentation 52 years).
| Overall and study sample size
The total number of subjects across all studies was 47 patients. The largest study had 16 participants while the smallest included manuscript had 1 subject. 9, 10, 12, [17] [18] [19] [20] 23 The mean sample size of all included studies was 3.5 (SD 40.8).
| Male to female ratio
There were more males than females with a male to female ratio of 2.5:1.
| Region of study origin
Among the 15 studies, three were conducted in the United States 8, 17 and Germany, respectively, and one in Turkey, 18 United Kingdom, 
| Diagnosis and location
Unilateral swelling over the parotid area containing clear fluid in the case of sialocele or clear fluid draining from the skin defect in salivary fistula, were reported throughout most studies.
The most common diagnostic test was a salivary amylase level, which was elevated. This is obtained either via aspiration of the sialocele, or by collection of clear fluid draining from the fistula. CT scan and ultrasound was also helpful in some cases to confirm the diagnosis.
The most common anatomical site involved was parotid glandular tissue, which was the more commonly injured than the parotid duct. Parotid fistulas occurred more frequently than parotid sialoceles. 
T A B L E 2 (Continued)
| Success rates
The overall success rate for patients treated with single dose Botox A injection was between 70 and 100% for parotid sialocele and fistula.
Patients who failed initial treatment with Botox A were given repeated doses and resolved. In cases of iatrogenic parotid fistula post-tumor excision, radiotherapy was administered in addition to the Botox injection, which aided in symptom resolution.
Glycopyrrolate and compression dressings may also be used simultaneously as conservative treatment options with Botox A injections.
Duration of response to therapy may be affected by the size of the fistula, patient's nutritional status, comorbidities, and amount of residual glandular tissue present. Follow-up periods with complete resolution ranged from 10 days to 21 months depending on whether the patient required multiple injections and concomitant post-op radiotherapy.
| DISCUSSION
Management of patients with parotid sialocele is a contentious issue due to the variety of treatment options and paucity of studies of an adequate size. In reviewing the literature, the following trends are evident.
The etiology of parotid sialocele and fistula is most commonly iatrogenic, with trauma being the second most common cause of injury.
Parotidectomy for tumor excision is the most common procedure associated with sialocele and fistula formation.
Clinical presentation includes that of a painless swelling around the parotid gland or duct and may be complicated by fistula formation and infection. 3 Patients may also present with aesthetic concerns as the swelling may continue to enlarge if not managed.
Radiologic investigations may aid in diagnosis, assist in evaluation of extent of the site affected and thereby assist in management strategies for sialocele. Fistulography refers to a technique in which radiopaque contrast is injected into the fistula, often under fluoroscopic guidance to visualize the extent of the tract. 3, 4 Sialography involves cannulation of the opening of the duct and injection of water-soluble contrast and provides useful information about the extent of ductal injury. 3, 4 Ultrasonography may demonstrate a cystic lesion which contains complex fluid. 4 CT fistulography or CT sialography may also demonstrate the extent of anatomical disruption and will show a simple or multiloculated cystic mass with smooth borders, and of lower density than surrounding structures. 4 MRI is usually unnecessary but may indicate a cystic mass with low signal intensity on T1-weighted imaging and high signal intensity on T2 weighted imaging. Ligation of the parotid duct may result in glandular atrophy, and diminished saliva production as a result. 3 Parasympathetic denervation via sectioning of the auriculotemporal nerve may have a similar result.
5
Superficial total parotidectomy may also be performed. 5 Surgical procedures are, however, invasive and may not always have successful results. 5, 6 Conservative management options include repeated aspirations and compression dressings, antisialagogue use and radiotherapy at a dose of 6 to 20 Gy. 5 Botox use for persistent parotid sialocele is recognized as a viable option to surgical management. 7 There is however, limited documented evidence on the use of Botox in sialoceles involving the parotid duct. 5, 6 Botox A is a neurotoxin, which inhibits presynaptic acetylcholine release. 3 It acts locally, with minimal side effects and its use for facial cosmetics, sialorrhea and sialocele is widely documented. 8 The method of administration and optimal therapeutic dose of Botox, however, is still contentious. 8 There is also no clear evidence on the use of percutaneous Botox A injection for sialocele resulting from complete transection of the parotid duct.
| Strengths and limitations of review
One of the main strengths of this review is the breadth of the search strategy. There has been one previous systematic review that examined the efficacy of Botox A in postsurgical parotid fistula. This study was published in April 2019 and included nine studies of botulinum toxin used in the treatment of a total of 25 patients.
Our review has been able to include a number of studies published since then. Our review includes 15 studies of a total of 47 patients.
| CONCLUSION
In this review article, the majority of sialoceles and fistulas presented as a complication of surgery (77%) with the remaining cases occurring as a result of trauma. Surgery performed included parotidectomy for tumor excision and Mohs micrographic surgery. Surgery was performed for diagnosis of squamous cell carcinoma in most cases.
The typical age at presentation was between 32 and 88 years of age (mean age of presentation 52 years).
The most common diagnostic test is the salivary amylase level, which is elevated. This is obtained either via aspiration of the sialocele, or by collection of clear fluid draining from the fistula. CT scan and ultrasound was also helpful in some cases to confirm the diagnosis.
Botox A injection was considered as a final conservative treatment option. All patients were initially treated conservatively and failed to respond to other conservative management strategies. The toxin was administered percutaneously in all cases of parotid sialocele and fistula.
The success rate for patients in this review, on initial treatment with Botox A injection was between 70 and 100% for parotid sialocele and fistula. Patients who did not respond after the first treatment were re-administered with Botox A and eventually resolved.
This systematic review has critically appraised the available evidence on the effectiveness of Botox A injections as an intervention to manage parotid sialoceles and fistulas. The review process has highlighted the paucity of existing evidence to support botulinum toxin A treatments for salivary sialocele and fistula, the lack of randomized controlled trials in this area, and highlights the need for further studies. Due to the small number of subjects and the variable quality of the study designs included in this review, the results must be interpreted with caution.
